Gathii Kimita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gathii Kimita has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- John Waitumbi
Basic Science Laboratory, Kenya Medical Research Institute (KEMRI)/Walter Reed Army Institute of Research-Africa, Kisumu, Kenya
8 shared publications - Allan Lemtudo
Affiliation Kenya Medical Research Institute/Walter Reed Army Institute of Research-Africa, Basic Science Laboratory, Kisumu, Kenya
5 shared publications - Beth Mutai
Kenya Medical Research Institute/US Army Medical Research Directorate–Africa/Kenya, Basic Science Laboratory. Off Kisumu - Kakamega Highway, Kisumu, Kenya
4 shared publications George Awinda
Kenya Medical Research Institute/Walter Reed Army Institute of Research-Africa, Basic Science Laboratory, Kisumu, Kenya
4 shared publicationsBeth Mutai
Kenya Medical Research Institute/Walter Reed Army Institute of Research-Africa, Basic Science Laboratory, Kisumu, Kenya
3 shared publications- Clement Masakhwe
Affiliation Kenya Medical Research Institute/Walter Reed Army Institute of Research-Africa, Basic Science Laboratory, Kisumu, Kenya
3 shared publications
Latest Publications
- Open Access
- 23 October 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (10) , e0004773
Phenotypic markers misclassify isolates of Salmonella Typhimurium as S. Typhi, but were correctly identified by whole genome sequencing during a septicemia study in western Kenya
Antimicrobial resistance (AMR) is a rising global health threat and estimated to cause 700,000 deaths annually. Although blood cultures (BCs) are the reference standard to diagnose bloodstream infections and inference of antimicrobial susceptibility testing (AST), the method could fail to differentiate bacteria with similar biochemical characteristics. This study compared phenotypic method (AST) and whole genome sequencing (WGS) in bacterial species identification and assessment of AMR. Blood samples came from children who had been prescribed antibiotics at admission at the county referral hospitals in western Kenya and around the Lake Victoria region. BCs and AST were performed on BD Bactec 9050 and Phoenix 100 respectively. Out of the 960 BCs, 17 isolates were useable and were evaluated by WGS on the Oxford Nanopore PromethION platform. BD Phoenix system identified the 17 bacteria isolates as: 4 Escherichia coli , 8 Salmonella enterica serovar Typhi, 1 unspeciated Salmonella , 3 Staphylococcus aureus and 1 Streptococcus pneumoniae . WGS results differed from BCs in identifying the 9 Salmonella species, with WGS identifying the species as Salmonella enterica serovar Typhimurium. Conversely, WGS detected AMR determinants in bacteria that AST had classified as susceptible. In conclusion, we caution that BCs may not be providing correct identity of Salmonella species. The observed discrepancies between phenotypic and genotypic markers of drug resistance highlight the challenges in interpreting and predicting the functional utility of AMR determinants.
- 23 October 2025
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 5 (10) , e0004773
Open AccessPhenotypic markers misclassify isolates of Salmonella Typhimurium as S. Typhi, but were correctly identified by whole genome sequencing during a septicemia study in western Kenya
Antimicrobial resistance (AMR) is a rising global health threat and estimated to cause 700,000 deaths annually. Although blood cultures (BCs) are the reference standard to diagnose bloodstream infections and inference of antimicrobial susceptibility testing (AST), the method could fail to differentiate bacteria with similar biochemical characteristics. This study compared phenotypic method (AST) and whole genome sequencing (WGS) in bacterial species identification and assessment of AMR. Blood samples came from children who had been prescribed antibiotics at admission at the county referral hospitals in western Kenya and around the Lake Victoria region. BCs and AST were performed on BD Bactec 9050 and Phoenix 100 respectively. Out of the 960 BCs, 17 isolates were useable and were evaluated by WGS on the Oxford Nanopore PromethION platform. BD Phoenix system identified the 17 bacteria isolates as: 4 Escherichia coli , 8 Salmonella enterica serovar Typhi, 1 unspeciated Salmonella , 3 Staphylococcus aureus and 1 Streptococcus pneumoniae . WGS results differed from BCs in identifying the 9 Salmonella species, with WGS identifying the species as Salmonella enterica serovar Typhimurium. Conversely, WGS detected AMR determinants in bacteria that AST had classified as susceptible. In conclusion, we caution that BCs may not be providing correct identity of Salmonella species. The observed discrepancies between phenotypic and genotypic markers of drug resistance highlight the challenges in interpreting and predicting the functional utility of AMR determinants.
- Open Access
- 24 February 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 154, 107862
Detection of zika virus disease caused by the Asian lineage of the zika virus at Kenya's Lamu island
- 24 February 2025
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 154, 107862
Open AccessDetection of zika virus disease caused by the Asian lineage of the zika virus at Kenya's Lamu island
- Open Access
- 10 September 2024
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 13 (9) , e0036624
Complete coding sequence of Rift Valley fever virus identified by metagenomic sequencing in patient with undifferentiated febrile illness at Marigat sub-district hospital, Kenya
We report on the complete coding sequence of Rift Valley Fever Virus inadvertently identified through metagenomics in a child with undifferentiated fever at Marigat sub-county hospital, Kenya. On phylogeny, the genome clustered with sequences obtained during the 2017 human outbreak in Uganda and the 2021 cattle outbreak in Kiambu, Kenya.
- 10 September 2024
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 13 (9) , e0036624
Open AccessComplete coding sequence of Rift Valley fever virus identified by metagenomic sequencing in patient with undifferentiated febrile illness at Marigat sub-district hospital, Kenya
We report on the complete coding sequence of Rift Valley Fever Virus inadvertently identified through metagenomics in a child with undifferentiated fever at Marigat sub-county hospital, Kenya. On phylogeny, the genome clustered with sequences obtained during the 2017 human outbreak in Uganda and the 2021 cattle outbreak in Kiambu, Kenya.
- Open Access
- 17 August 2022
- Published by Springer Nature in Communications Medicine
- Vol. 2 (1) , 1-13
Temporal lineage replacements and dominance of imported variants of concern during the COVID-19 pandemic in Kenya
Background: Kenya’s COVID-19 epidemic was seeded early in March 2020 and did not peak until early August 2020 (wave 1), late-November 2020 (wave 2), mid-April 2021 (wave 3), late August 2021 (wave 4), and mid-January 2022 (wave 5). Methods: Here, we present SARS-CoV-2 lineages associated with the five waves through analysis of 1034 genomes, which included 237 non-variants of concern and 797 variants of concern (VOC) that had increased transmissibility, disease severity or vaccine resistance. Results: In total 40 lineages were identified. The early European lineages (B.1 and B.1.1) were the first to be seeded. The B.1 lineage continued to expand and remained dominant, accounting for 60% (72/120) and 57% (45/79) in waves 1 and 2 respectively. Waves three, four and five respectively were dominated by VOCs that were distributed as follows: Alpha 58.5% (166/285), Delta 92.4% (327/354), Omicron 95.4% (188/197) and Beta at 4.2% (12/284) during wave 3 and 0.3% (1/354) during wave 4. Phylogenetic analysis suggests multiple introductions of variants from outside Kenya, more so during the first, third, fourth and fifth waves, as well as subsequent lineage diversification. Conclusions: The data highlights the importance of genome surveillance in determining circulating variants to aid interpretation of phenotypes such as transmissibility, virulence and/or resistance to therapeutics/vaccines.
- 17 August 2022
- Published by Springer Nature in Communications Medicine
- Vol. 2 (1) , 1-13
Open AccessTemporal lineage replacements and dominance of imported variants of concern during the COVID-19 pandemic in Kenya
Background: Kenya’s COVID-19 epidemic was seeded early in March 2020 and did not peak until early August 2020 (wave 1), late-November 2020 (wave 2), mid-April 2021 (wave 3), late August 2021 (wave 4), and mid-January 2022 (wave 5). Methods: Here, we present SARS-CoV-2 lineages associated with the five waves through analysis of 1034 genomes, which included 237 non-variants of concern and 797 variants of concern (VOC) that had increased transmissibility, disease severity or vaccine resistance. Results: In total 40 lineages were identified. The early European lineages (B.1 and B.1.1) were the first to be seeded. The B.1 lineage continued to expand and remained dominant, accounting for 60% (72/120) and 57% (45/79) in waves 1 and 2 respectively. Waves three, four and five respectively were dominated by VOCs that were distributed as follows: Alpha 58.5% (166/285), Delta 92.4% (327/354), Omicron 95.4% (188/197) and Beta at 4.2% (12/284) during wave 3 and 0.3% (1/354) during wave 4. Phylogenetic analysis suggests multiple introductions of variants from outside Kenya, more so during the first, third, fourth and fifth waves, as well as subsequent lineage diversification. Conclusions: The data highlights the importance of genome surveillance in determining circulating variants to aid interpretation of phenotypes such as transmissibility, virulence and/or resistance to therapeutics/vaccines.
- Open Access
- 21 July 2022
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 6
COVID-19 mass testing and sequencing: Experiences from a laboratory in Western Kenya
Background: The Basic Science Laboratory (BSL) of the Kenya Medical Research Institute/Walter Reed Project in Kisumu, Kenya addressed mass testing challenges posed by the emergent coronavirus disease 2019 (COVID-19) in an environment of global supply shortages. Before COVID-19, the BSL had adequate resources for disease surveillance and was therefore designated as one of the testing centres for COVID-19. Intervention: By April 2020, the BSL had developed stringent safety procedures for receiving and mass testing potentially infectious nasal specimens. To accommodate increased demand, BSL personnel worked in units: nucleic acid extraction, polymerase chain reaction, and data and quality assurance checks. The BSL adopted procedures for tracking sample integrity and minimising cross-contamination. Lessons learnt: Between May 2020 and January 2022, the BSL tested 63 542 samples, of which 5375 (8.59%) were positive for COVID-19; 1034 genomes were generated by whole genome sequencing and deposited in the Global Initiative on Sharing All Influenza Data database to aid global tracking of viral lineages. At the height of the pandemic (August and November 2020, April and August 2021 and January 2022), the BSL was testing more than 500 samples daily, compared to 150 per month prior to COVID-19. An important lesson from the COVID-19 pandemic was the discovery of untapped resilience within BSL personnel that allowed adaptability when the situation demanded. Strict safety procedures and quality management that are often difficult to maintain became routine. Recommendations: A fundamental lesson to embrace is that there is no ‘one-size-fits-all’ approach and adaptability is the key to success.
- 21 July 2022
- Published by AOSIS in African Journal of Laboratory Medicine
- Vol. 11 (1) , 6
Open AccessCOVID-19 mass testing and sequencing: Experiences from a laboratory in Western Kenya
Background: The Basic Science Laboratory (BSL) of the Kenya Medical Research Institute/Walter Reed Project in Kisumu, Kenya addressed mass testing challenges posed by the emergent coronavirus disease 2019 (COVID-19) in an environment of global supply shortages. Before COVID-19, the BSL had adequate resources for disease surveillance and was therefore designated as one of the testing centres for COVID-19. Intervention: By April 2020, the BSL had developed stringent safety procedures for receiving and mass testing potentially infectious nasal specimens. To accommodate increased demand, BSL personnel worked in units: nucleic acid extraction, polymerase chain reaction, and data and quality assurance checks. The BSL adopted procedures for tracking sample integrity and minimising cross-contamination. Lessons learnt: Between May 2020 and January 2022, the BSL tested 63 542 samples, of which 5375 (8.59%) were positive for COVID-19; 1034 genomes were generated by whole genome sequencing and deposited in the Global Initiative on Sharing All Influenza Data database to aid global tracking of viral lineages. At the height of the pandemic (August and November 2020, April and August 2021 and January 2022), the BSL was testing more than 500 samples daily, compared to 150 per month prior to COVID-19. An important lesson from the COVID-19 pandemic was the discovery of untapped resilience within BSL personnel that allowed adaptability when the situation demanded. Strict safety procedures and quality management that are often difficult to maintain became routine. Recommendations: A fundamental lesson to embrace is that there is no ‘one-size-fits-all’ approach and adaptability is the key to success.
- Open Access
- 24 March 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (3) , e0000122
March 2019 dengue fever outbreak at the Kenyan south coast involving dengue virus serotype 3, genotypes III and V
The first description of a disease resembling dengue fever (DF) was in the 15thcentury slave trade era by Spanish sailors visiting the Tanzania coast. The disease, then associated with evil spirits is now known to be caused by four serotypes of dengue virus (DENV1-4) that are transmitted byAedesmosquitoes. Kenya has experienced multiple outbreaks, mostly associated with DENV-2. In this study, plasma samples obtained from 37 febrile patients during a DF outbreak at Kenya’s south coast in March 2019 were screened for DENV. Total RNA was extracted and screened for the alpha- andflavi-viruses by real-time polymerase chain reaction (qPCR). DENV-3 was the only virus detected. Shotgun metagenomics and targeted sequencing were used to obtain DENV whole genomes and the complete envelope genes (E gene) respectively. Sequences were used to infer phylogenies and time-scaled genealogies. Following Maximum likelihood and Bayesian phylogenetic analysis, two DENV-3 genotypes (III, n = 15 and V, n = 2) were found. We determined that the two genotypes had been in circulation since 2015, and that both had been introduced independently. Genotype III’s origin was estimated to have been from Pakistan. Although the origin of genotype V could not be ascertained due to rarity of these sequences globally, it was most related to a 2006 Brazilian isolate. Unlike genotype III that has been described in East and West Africa multiple times, this was the second description of genotype V in Kenya. Of note, there was marked amino acid variances in the E gene between study samples and the Thailand DENV-3 strain used in the approved Dengvaxia vaccine. It remains to be seen whether these variances negatively impact the efficacy of the Dengvaxia or future vaccines.
- 24 March 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (3) , e0000122
Open AccessMarch 2019 dengue fever outbreak at the Kenyan south coast involving dengue virus serotype 3, genotypes III and V
The first description of a disease resembling dengue fever (DF) was in the 15thcentury slave trade era by Spanish sailors visiting the Tanzania coast. The disease, then associated with evil spirits is now known to be caused by four serotypes of dengue virus (DENV1-4) that are transmitted byAedesmosquitoes. Kenya has experienced multiple outbreaks, mostly associated with DENV-2. In this study, plasma samples obtained from 37 febrile patients during a DF outbreak at Kenya’s south coast in March 2019 were screened for DENV. Total RNA was extracted and screened for the alpha- andflavi-viruses by real-time polymerase chain reaction (qPCR). DENV-3 was the only virus detected. Shotgun metagenomics and targeted sequencing were used to obtain DENV whole genomes and the complete envelope genes (E gene) respectively. Sequences were used to infer phylogenies and time-scaled genealogies. Following Maximum likelihood and Bayesian phylogenetic analysis, two DENV-3 genotypes (III, n = 15 and V, n = 2) were found. We determined that the two genotypes had been in circulation since 2015, and that both had been introduced independently. Genotype III’s origin was estimated to have been from Pakistan. Although the origin of genotype V could not be ascertained due to rarity of these sequences globally, it was most related to a 2006 Brazilian isolate. Unlike genotype III that has been described in East and West Africa multiple times, this was the second description of genotype V in Kenya. Of note, there was marked amino acid variances in the E gene between study samples and the Thailand DENV-3 strain used in the approved Dengvaxia vaccine. It remains to be seen whether these variances negatively impact the efficacy of the Dengvaxia or future vaccines.
- Open Access
- 18 October 2021
- Published by Springer Nature in Research Square
A genomics dissection of Kenya’s COVID-19 waves: temporal lineage replacements and dominance of imported variants of concern
Kenya’s COVID-19 epidemic was slow to peak. It was seeded early in March 2020, and did not peak until late-July 2020 (wave 1), mid-November 2020 (wave 2) and late-March 2021 (wave 3). Here we present SARS-CoV-2 lineages associated with the three COVID-19 waves through analysis of 483 genomes, which included 167 Alpha (B.1.1.7), 57 Delta (B.1.617.2) and 12 Beta (B.1.351) variants of concerns (VOC) that dominated the third wave. In total, 35 lineages were identified. The early European lineages B.1 and B.1.1 were the first to be seeded in Kenya. The B.1 lineage continued to expand and remained the most dominant lineage accounting for 55.8% and 56.3% in waves 1 and 2 respectively. The alpha (B.1.1.7), delta (B.1.167.2) and beta (B.1.351) VOCs dominated in wave 3 at 59.0%, 20.1% and 4.2% respectively. Eventually, the delta variant took over at the tail end of wave 3 and at the time of going to press, it had become the major lineage in the whole country. Phylogenetic analysis suggested multiple introductions of variants from outside Kenya especially during the first and third wave. Phylogeny also highlighted local lineage diversification as local transmission events supervened. The data highlights the importance of genome surveillance in determining circulating variants to aid in public health interventions.
- 18 October 2021
- Published by Springer Nature in Research Square
Open AccessA genomics dissection of Kenya’s COVID-19 waves: temporal lineage replacements and dominance of imported variants of concern
Kenya’s COVID-19 epidemic was slow to peak. It was seeded early in March 2020, and did not peak until late-July 2020 (wave 1), mid-November 2020 (wave 2) and late-March 2021 (wave 3). Here we present SARS-CoV-2 lineages associated with the three COVID-19 waves through analysis of 483 genomes, which included 167 Alpha (B.1.1.7), 57 Delta (B.1.617.2) and 12 Beta (B.1.351) variants of concerns (VOC) that dominated the third wave. In total, 35 lineages were identified. The early European lineages B.1 and B.1.1 were the first to be seeded in Kenya. The B.1 lineage continued to expand and remained the most dominant lineage accounting for 55.8% and 56.3% in waves 1 and 2 respectively. The alpha (B.1.1.7), delta (B.1.167.2) and beta (B.1.351) VOCs dominated in wave 3 at 59.0%, 20.1% and 4.2% respectively. Eventually, the delta variant took over at the tail end of wave 3 and at the time of going to press, it had become the major lineage in the whole country. Phylogenetic analysis suggested multiple introductions of variants from outside Kenya especially during the first and third wave. Phylogeny also highlighted local lineage diversification as local transmission events supervened. The data highlights the importance of genome surveillance in determining circulating variants to aid in public health interventions.
- Open Access
- 7 July 2016
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 10 (7) , e0004788
Phylogenetic Variants of Rickettsia africae, and Incidental Identification of "Candidatus Rickettsia Moyalensis" in Kenya
Rickettsia africae, the etiological agent of African tick bite fever, is widely distributed in sub-Saharan Africa. Contrary to reports of its homogeneity, a localized study in Asembo, Kenya recently reported high genetic diversity. The present study aims to elucidate the extent of this heterogeneity by examining archived Rickettsia africae DNA samples collected from different eco-regions of Kenya. To evaluate their phylogenetic relationships, archived genomic DNA obtained from 57 ticks a priori identified to contain R. africae by comparison to ompA, ompB and gltA genes was used to amplify five rickettsial genes i.e. gltA, ompA, ompB, 17kDa and sca4. The resulting amplicons were sequenced. Translated amino acid alignments were used to guide the nucleotide alignments. Single gene and concatenated alignments were used to infer phylogenetic relationships. Out of the 57 DNA samples, three were determined to be R. aeschlimanii and not R. africae. One sample turned out to be a novel rickettsiae and an interim name of “Candidatus Rickettsia moyalensis” is proposed. The bonafide R. africae formed two distinct clades. Clade I contained 9% of the samples and branched with the validated R. africae str ESF-5, while clade II (two samples) formed a distinct sub-lineage. This data supports the use of multiple genes for phylogenetic inferences. It is determined that, despite its recent emergence, the R. africae lineage is diverse. This data also provides evidence of a novel Rickettsia species, Candidatus Rickettsia moyalensis. Rickettsia africae is a bacterium mainly vectored by Amblyomma and Rhipicephalus species of ticks. It is the etiological agent of African tick bite fever (ATBF), a spotted fever rickettsiosis that presents as an acute febrile illness characterized by petecheal skin hemorrhages, from which the name is derived. This bacterium is probably the most important in sub-Saharan Africa, including Kenya, in terms of incidence and prevalence. This notwithstanding, the disease is poorly understood and is often mistreated as malaria, and therefore qualifies as a highly neglected disease. This study examined the genetic relationships of R. africae collected from diverse eco-regions of Kenya. We present data that indicate high genetic diversity in Kenya’s R. africae and corroborate a recent study that reported similar genetic diversity in R. africae samples collected from a localized area in western Kenya. Importantly, we describe a divergent lineage and propose the name Candidatus Rickettsia moyalensis.
- 7 July 2016
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 10 (7) , e0004788
Open AccessPhylogenetic Variants of Rickettsia africae, and Incidental Identification of "Candidatus Rickettsia Moyalensis" in Kenya
Rickettsia africae, the etiological agent of African tick bite fever, is widely distributed in sub-Saharan Africa. Contrary to reports of its homogeneity, a localized study in Asembo, Kenya recently reported high genetic diversity. The present study aims to elucidate the extent of this heterogeneity by examining archived Rickettsia africae DNA samples collected from different eco-regions of Kenya. To evaluate their phylogenetic relationships, archived genomic DNA obtained from 57 ticks a priori identified to contain R. africae by comparison to ompA, ompB and gltA genes was used to amplify five rickettsial genes i.e. gltA, ompA, ompB, 17kDa and sca4. The resulting amplicons were sequenced. Translated amino acid alignments were used to guide the nucleotide alignments. Single gene and concatenated alignments were used to infer phylogenetic relationships. Out of the 57 DNA samples, three were determined to be R. aeschlimanii and not R. africae. One sample turned out to be a novel rickettsiae and an interim name of “Candidatus Rickettsia moyalensis” is proposed. The bonafide R. africae formed two distinct clades. Clade I contained 9% of the samples and branched with the validated R. africae str ESF-5, while clade II (two samples) formed a distinct sub-lineage. This data supports the use of multiple genes for phylogenetic inferences. It is determined that, despite its recent emergence, the R. africae lineage is diverse. This data also provides evidence of a novel Rickettsia species, Candidatus Rickettsia moyalensis. Rickettsia africae is a bacterium mainly vectored by Amblyomma and Rhipicephalus species of ticks. It is the etiological agent of African tick bite fever (ATBF), a spotted fever rickettsiosis that presents as an acute febrile illness characterized by petecheal skin hemorrhages, from which the name is derived. This bacterium is probably the most important in sub-Saharan Africa, including Kenya, in terms of incidence and prevalence. This notwithstanding, the disease is poorly understood and is often mistreated as malaria, and therefore qualifies as a highly neglected disease. This study examined the genetic relationships of R. africae collected from diverse eco-regions of Kenya. We present data that indicate high genetic diversity in Kenya’s R. africae and corroborate a recent study that reported similar genetic diversity in R. africae samples collected from a localized area in western Kenya. Importantly, we describe a divergent lineage and propose the name Candidatus Rickettsia moyalensis.